Skip to main content
Insights into Imaging
Fig. 11 | Insights into Imaging

Fig. 11

From: How clinical imaging can assess cancer biology

Fig. 11

Theranostic in oncology with PSMA. 177Lu-PSMA radioligand therapy in a 67-year-old man with metastatic castration-resistant prostate cancer. a Pretherapy. PET image evidenced a difuse metastatic involvement. PSA value 50 ng/ml. b 4 months following the treatment with 177Lu-PSMA radioligand therapy (8000 MBq), PET showed a complete metabolic response. PSA value 0 ng/ml

Back to article page